Corrigendum to “Effect of chiglitazar and sitagliptin on glucose variations, insulin resistance and inflammatory-related biomarkers in untreated patients with type 2 diabetes” [Diabetes Res. Clin. Pract. 183 (2022) 109171]

The authors regret that an error occurred in the spelling of corresponding author's name, Jiahuan Ma. The correct spelling is updated as above.In addition, Table 2 had errors for the P value in changes of TIR, TAR and TBR. The corrected Table is reproduced below.Table 2Comparison of blood fluctuation within groups before and after 24 weeks treatment and the changes from baseline to week 24 between two groups.Chiglitazar group (N = 39)Sitagliptin group (N = 17)ChangesBeforeAfterPBeforeAfterPChiglitazarSitagliptinPMBG (mmol/L)10.11 ± 2.198.24 ± 1.64<0.00110.28 ± 2.228.08 ± 1.49<0.001−1.86 ± 0.32−2.20 ± 0.570.584SD(mmol/L)1.98 ± 0.761.55 ± 0.610.0012.08 ± 0.940.96 ± 0.38<0.001−0.43 ± 0.12−1.12 ± 0.220.004MAGE(mmol/L)4.83 ± 2.153.74 ± 1.700.0045.23 ± 2.022.58 ± 1.21<0.001−1.08 ± 0.35−2.64 ± 0.430.013TIR (3.9-10mmol/L, %)56.94(23.96, 87.15)86.11(68.40, 99.65)<0.00152.43(17.36, 83.68)98.96(79.17, 100)0.00517.01(4.51, 51.39)37.50(8.51, 68.06)0.209TAR (>10mmol/L, %)43.06(12.85, 76.04)13.89(0, 31.60)<0.00145.57(16.32, 82.64)1.04(0, 20.83)0.005−17.71(−51.39, −5.21)−37.50(−68.06, −8.51)0.215TBR (<3.9mmol/L, %)0(0, 0)0(0, 0)0.1020(0, 0)0(0, 0)10(0, 0)0(0, 0)0.244MBG: mean blood glucose (mmol/L); SD: standard deviation of mean blood glucose (mmol/L); MAGE: mean amplitude of glycemic excursions (mmol/L); TIR: time in range: percentage of time in the range of 3.9–10 mmol/L; TAR: time above range: percentage of time >10 mmol/L; TBR: time below range: percentage of time <3.9 mmol/L. Data shown as mean ± SEM. Open table in a new tab The authors would like to apologise for any inconvenience caused. The authors regret that an error occurred in the spelling of corresponding author's name, Jiahuan Ma. The correct spelling is updated as above. In addition, Table 2 had errors for the P value in changes of TIR, TAR and TBR. The corrected Table is reproduced below. MBG: mean blood glucose (mmol/L); SD: standard deviation of mean blood glucose (mmol/L); MAGE: mean amplitude of glycemic excursions (mmol/L); TIR: time in range: percentage of time in the range of 3.9–10 mmol/L; TAR: time above range: percentage of time >10 mmol/L; TBR: time below range: percentage of time <3.9 mmol/L. Data shown as mean ± SEM. The authors would like to apologise for any inconvenience caused. Effect of chiglitazar and sitagliptin on glucose variations, insulin resistance and inflammatory-related biomarkers in untreated patients with type 2 diabetesDiabetes Research and Clinical PracticeVol. 183PreviewTo evaluate glycemic variations, changes in insulin resistance and oxidative stress after chiglitazar or sitagliptin treatment in untreated patients with type 2 diabetes mellitus (T2DM). Full-Text PDF